Register entry
AKS KOZMETIK TARIM URUNLERI KIMYA GIDA TEMIZLIK MAD INSAAT SAN IC VE DIS TIC LTD STI
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- Turkey
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1particle size reduction1Relabelling1Repackaging1sterilize1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| AKS KOZMETIK TARIM URUNLERI KIMYA GIDA TEMIZLIK MAD INSAAT SAN IC VE DIS TIC LTD STI | OSTIM, NO:1-55 OSTIM MAHALLESI GUL-86, Yenimahalle, Ankara 06374, Turkey (TUR) | Analytical testing, Labelling, Finished drug manufacture, Packaging, particle size reduction, Relabelling, Repackaging, sterilize | 3024447099503023191 |
Compare
Comparable companies in Turkey
- DALAN KIMYA ENDUSTRI ANONIM SIRKETI1 site · 13 NDC
- SBS BILIMSEL BIO COZUMLER SANAYI VE TICARET ANONIM SIRKETI PINAR SUBESI1 site · 9 NDC
- SORA KOZMETIK SANAYI TICARET ANONIM SIRKETI1 site · 3 NDC
- TURKUAZ SAGLIK HIZMETLERI MEDIKAL TEMIZLIK KIMYASAL URUNLER SANAYI VE TICARET AS1 site · 3 NDC
- SEYITLER KIMYA SANAYI ANONIM SIRKETI1 site · 1 NDC
- Deva Holding A S2 sites · 0 NDC
Enquiry
Common questions
- Is AKS KOZMETIK TARIM URUNLERI KIMYA GIDA TEMIZLIK MAD INSAAT SAN IC VE DIS TIC LTD STI FDA approved?
- AKS KOZMETIK TARIM URUNLERI KIMYA GIDA TEMIZLIK MAD INSAAT SAN IC VE DIS TIC LTD STI holds 1 FDA-registered establishment in Turkey. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are AKS KOZMETIK TARIM URUNLERI KIMYA GIDA TEMIZLIK MAD INSAAT SAN IC VE DIS TIC LTD STI's drugs manufactured?
- The FDA register lists Yenimahalle. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, particle size reduction, relabelling, repackaging, sterilize.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.